Sartorius AG ST buy Traumtanz
Start price
10.12.24
/
50%
€187.80
Target price
10.01.25
-
Performance (%)
-9.48%
End price
01.01.25
€170.00
Summary
This prediction ended on 01.01.25 with a price of €170.00. With a performance of -9.48%, the BUY prediction for Sartorius AG ST by Traumtanz closed slightly in the red. Traumtanz has 50% into this predictionSartorius is a German-based biotech and laboratory equipment company that is listed on the Frankfurt Stock Exchange under the symbol SARTF. The company provides products and services for the pharmaceutical, biotech, and food industries, including laboratory instruments, consumables, and services. Sartorius has a global presence with operations in Europe, Asia, and the Americas, and has a strong reputation for innovation, quality, and reliability. The company's stock has performed well in recent years, reflecting its solid financial results and growth prospects in the life sciences industry.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sartorius AG ST | -3.464% | -3.464% |
| iShares Core DAX® | -0.727% | 2.783% |
| iShares Nasdaq 100 | 1.839% | 5.294% |
| iShares Nikkei 225® | -2.033% | -0.196% |
| iShares S&P 500 | 1.334% | 4.044% |
According to Traumtanz what are the pros and cons of Sartorius AG ST for the foreseeable future?
Pros
Cons
Revenue decline/stagnation expected
EBIT decline/stagnation expected
negative Cash Flow expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
Bad rating
Risky balance sheet
Increased challenges to pay loans and raise capital
Little Investments for future growth
ROE lower than 10% per year
Comments by Traumtanz for this prediction
In the thread Trading Sartorius AG
Stopped prediction by Traumtanz for Sartorius AG ST
Sartorius AG ST
Start price
Target price
Perf. (%)
€222.00
28.01.25
28.01.25
€200.00
31.03.25
31.03.25
-1.58%
29.01.25
29.01.25
Revenue decline/stagnation expected
EBIT decline/stagnation expected
negative Cash Flow expected
Lower EBIT Margin than peer group
Sartorius AG ST
Start price
Target price
Perf. (%)
€172.60
18.11.24
18.11.24
€170.00
18.11.25
18.11.25
-2.20%
20.11.24
20.11.24
Revenue decline/stagnation expected
EBIT decline/stagnation expected
negative Cash Flow expected
Lower EBIT Margin than peer group